HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 51 filers reported holding HARPOON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | -34.1% | 11,200 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $85,000 | -3.4% | 11,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -52.9% | 11,200 | -17.1% | 0.00% | -66.7% |
| Q2 2021 | $187,000 | -72.0% | 13,508 | -57.7% | 0.01% | -76.0% |
| Q1 2021 | $668,000 | +32.8% | 31,937 | -6.1% | 0.02% | -43.2% |
| Q4 2019 | $503,000 | – | 34,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,105,000 | 22.35% |
| MPM BioImpact LLC | 3,898,422 | $64,714,000 | 17.21% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,495,000 | 13.92% |
| Avidity Partners Management LP | 1,206,351 | $20,025,000 | 1.28% |
| Consonance Capital Management LP | 844,162 | $14,013,000 | 0.84% |
| Orbimed Advisors | 1,835,704 | $30,473,000 | 0.43% |
| Artal Group S.A. | 900,000 | $14,940,000 | 0.42% |
| Cormorant Asset Management, LP | 645,257 | $10,711,000 | 0.41% |
| DAFNA Capital Management LLC | 85,119 | $1,413,000 | 0.41% |
| Soleus Capital Management, L.P. | 30,886 | $512,000 | 0.29% |